Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

Share

Pharmalex Norway AS

Closing information (x1000 SEK)

Closing information 2023/09 2022/12 2021/12
Turnover 21,341 More Arrow 30,310 Less Arrow 23,518
Financial expenses 563 More Arrow 820 Less Arrow 529
Earnings before taxes 134 More Arrow 4,794 More Arrow 5,495
Total assets 7,152 More Arrow 12,173 Less Arrow 11,480
Current assets 7,077 More Arrow 11,828 Less Arrow 11,199
Current liabilities 3,517 More Arrow 8,512 Less Arrow 7,959
Equity capital 3,635 More Arrow 3,661 Less Arrow 3,521
- share capital 102 More Arrow 106 Less Arrow 103

Financial ratios

Fiscal year 2023/09 2022/12 2021/12
Solvency 50.8% Less Arrow 30.1% More Arrow 30.7%
Turnover per employee
Profit as a percentage of turnover 0.6% More Arrow 15.8% More Arrow 23.4%
Return on assets (ROA) 9.7% More Arrow 46.1% More Arrow 52.5%
Current ratio 201.2% Less Arrow 139.0% More Arrow 140.7%
Return on equity (ROE) 3.7% More Arrow 130.9% More Arrow 156.1%
Change turnover -7,908 More Arrow 6,064 More Arrow 9,066
Change turnover % -27% More Arrow 25% More Arrow 63%
Chg. No. of employees
Chg. No. of employees %

Total value of public sale

Fiscal year 2023/09 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.